Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
Wang
Jing
J
Department of Hematology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, PR China.
An
Li
L
Chen
Shi
S
Ouyang
Jian
J
Zhou
Rongfu
R
Chen
Bing
B
Yang
Yonggong
Y
D000208:Acute Disease; D000293:Adolescent; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D000078224:Lenograstim; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000401:mortality*; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D011994:Recombinant Proteins / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000078224:Lenograstim; D000069585:Filgrastim